BioSpace News Archive

Drug Development

Veloxis Pharmaceuticals A/S Release: Envarsus® XR Demonstrates Lower Treatment Failure Rate In African-Americans Compared To Twice-Daily Tacrolimus (Prograf®)

June 30, 2014
·
1 min read
Change In The Number Of Shares Outstanding In Sectra During June

June 30, 2014
·
1 min read
NicOx SA Launches Commercial Operations In Germany

June 30, 2014
·
1 min read
Lone Star Bio

Bio-Path Holdings, Inc. Added To Russell Global, Russell 3000® And Russell Microcap® Indexes

June 30, 2014
·
1 min read
Deals

Covidien plc Release: Announcement Under Irish Takeover Rules Relevant Securities In Issue

June 30, 2014
·
1 min read
Drug Development

Aclaris Therapeutics Announces Positive Results From Phase 2 Clinical Trial Of A-101 For The Removal Of Seborrheic Keratosis, A Common Type Of Skin Tumor

June 30, 2014
·
1 min read
FDA

Genzyme Corporation’s Lemtrada Approved In Argentina For Treatment Of Multiple Sclerosis

June 30, 2014
·
1 min read
Addex Therapeutics Shareholders Approve All Board Proposals At Annual General Meeting

June 30, 2014
·
4 min read
Drug Development

First Patient Enrolled In FDA Phase 1/2a Clinical Trial With Biolight’s Controlled-Release Latanoprost Insert For The Treatment Of Glaucoma

June 30, 2014
·
4 min read
Pharm Country

OLIGOMERIX To Present Its Drug Discovery Program Targeting Tau Oligomers At The Federation Of European Neuroscience Societies Forum And The Alzheimer’s Association International Conference®

June 30, 2014
·
2 min read